
Absentia is a next-generation drug discovery platform that leverages in-silico whole-organism models to replace traditional animal testing. By addressing the significant failure rates of animal models in translating to human outcomes, Absentia offers a more accurate, ethical, and cost-effective solution for drug discovery and development. The platform has already demonstrated capabilities in cell differentiation, reprogramming, drug absorption, tissue regeneration, and embryonic development in mice, with plans to scale and expand to other model organisms. This innovative approach aims to accelerate the drug discovery process while improving success rates, positioning Absentia as a transformative player in the pharmaceutical industry.

Absentia is a next-generation drug discovery platform that leverages in-silico whole-organism models to replace traditional animal testing. By addressing the significant failure rates of animal models in translating to human outcomes, Absentia offers a more accurate, ethical, and cost-effective solution for drug discovery and development. The platform has already demonstrated capabilities in cell differentiation, reprogramming, drug absorption, tissue regeneration, and embryonic development in mice, with plans to scale and expand to other model organisms. This innovative approach aims to accelerate the drug discovery process while improving success rates, positioning Absentia as a transformative player in the pharmaceutical industry.